Jana Blažková

2.4k total citations
31 papers, 1.1k citations indexed

About

Jana Blažková is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jana Blažková has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Virology, 15 papers in Infectious Diseases and 11 papers in Immunology. Recurrent topics in Jana Blažková's work include HIV Research and Treatment (22 papers), HIV/AIDS Research and Interventions (12 papers) and HIV/AIDS drug development and treatment (11 papers). Jana Blažková is often cited by papers focused on HIV Research and Treatment (22 papers), HIV/AIDS Research and Interventions (12 papers) and HIV/AIDS drug development and treatment (11 papers). Jana Blažková collaborates with scholars based in United States, Czechia and France. Jana Blažková's co-authors include Jiřı́ Hejnar, J. Shawn Justement, Susan Moir, Kateřina Trejbalová, Ivan Hirsch, Anthony S. Fauci, Tae‐Wook Chun, Françoise Gondois‐Rey, Philippe Halfon and Daniel Olive and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Jana Blažková

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jana Blažková United States 16 690 524 352 288 126 31 1.1k
Hind J. Fadel United States 17 693 1.0× 541 1.0× 534 1.5× 112 0.4× 263 2.1× 32 1.1k
Vincent Baillat France 16 836 1.2× 457 0.9× 540 1.5× 503 1.7× 194 1.5× 22 1.4k
Zhiyuan Yang United States 6 474 0.7× 182 0.3× 429 1.2× 564 2.0× 177 1.4× 8 1.0k
Gian Paolo Rizzardi Italy 19 861 1.2× 592 1.1× 208 0.6× 580 2.0× 327 2.6× 36 1.4k
Fiona Wightman Australia 17 944 1.4× 568 1.1× 247 0.7× 490 1.7× 326 2.6× 24 1.3k
John Delehanty United States 11 1.1k 1.6× 1.2k 2.2× 185 0.5× 152 0.5× 232 1.8× 13 1.5k
Hwee L. Ng United States 21 609 0.9× 190 0.4× 294 0.8× 722 2.5× 226 1.8× 49 1.2k
Yuyang Tang United States 12 464 0.7× 330 0.6× 250 0.7× 181 0.6× 126 1.0× 22 740
Catherine Riou South Africa 23 455 0.7× 751 1.4× 330 0.9× 742 2.6× 487 3.9× 56 1.5k

Countries citing papers authored by Jana Blažková

Since Specialization
Citations

This map shows the geographic impact of Jana Blažková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jana Blažková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jana Blažková more than expected).

Fields of papers citing papers by Jana Blažková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jana Blažková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jana Blažková. The network helps show where Jana Blažková may publish in the future.

Co-authorship network of co-authors of Jana Blažková

This figure shows the co-authorship network connecting the top 25 collaborators of Jana Blažková. A scholar is included among the top collaborators of Jana Blažková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jana Blažková. Jana Blažková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blažková, Jana, J. Shawn Justement, Victoria Shi, et al.. (2024). Timing of antiretroviral therapy initiation affects intact HIV reservoirs following analytical treatment interruption. Journal of Clinical Investigation. 134(20). 2 indexed citations
2.
3.
Blažková, Jana, et al.. (2023). Social Responsibility for Insurance Companies. MONTENEGRIN JOURNAL OF ECONOMICS. 19(2). 3 indexed citations
4.
Ali, Mohammad, Victoria Shi, J. Shawn Justement, et al.. (2023). Impact of Monkeypox Virus Infection on Immune Parameters in a Woman With Human Immunodeficiency Virus Receiving Clinically Effective Antiretroviral Therapy. The Journal of Infectious Diseases. 228(3). 270–275. 2 indexed citations
5.
Blažková, Jana, Victoria Shi, J. Shawn Justement, et al.. (2023). Immunologic and Virologic Parameters Associated With Human Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy. The Journal of Infectious Diseases. 229(6). 1770–1780. 1 indexed citations
6.
Sneller, Michael C., Jana Blažková, J. Shawn Justement, et al.. (2022). Combination anti-HIV antibodies provide sustained virological suppression. Nature. 606(7913). 375–381. 100 indexed citations
7.
Blažková, Jana, Feng Gao, Manukumar Honnayakanahalli Marichannegowda, et al.. (2021). Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy. Nature Medicine. 27(11). 1893–1898. 31 indexed citations
8.
Blažková, Jana, Erin Huiting, Arun K. Boddapati, et al.. (2021). Correlation Between TIGIT Expression on CD8+ T Cells and Higher Cytotoxic Capacity. The Journal of Infectious Diseases. 224(9). 1599–1604. 18 indexed citations
9.
Li, Haishan, Tyler Lahusen, Nidal Muvarak, et al.. (2020). Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure. Molecular Therapy — Methods & Clinical Development. 17. 1048–1060. 8 indexed citations
10.
Sneller, Michael C., Katherine E. Clarridge, Catherine Seamon, et al.. (2019). An open-label phase 1 clinical trial of the anti-α 4 β 7 monoclonal antibody vedolizumab in HIV-infected individuals. Science Translational Medicine. 11(509). 28 indexed citations
11.
Blažková, Jana, Eric W. Refsland, Katherine E. Clarridge, et al.. (2019). Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals. Journal of Clinical Investigation. 129(11). 4832–4837. 8 indexed citations
12.
Arakelyan, Anush, Jennifer D. Petersen, Jana Blažková, & Leonid Margolis. (2019). Macrophage-derived HIV-1 carries bioactive TGF-beta. Scientific Reports. 9(1). 19100–19100. 10 indexed citations
13.
Clarridge, Katherine E., Jana Blažková, Kevin Einkauf, et al.. (2018). Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals. PLoS Pathogens. 14(1). e1006792–e1006792. 66 indexed citations
14.
Blažková, Jana, Sarthak Gupta, Yudong Liu, et al.. (2017). Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy. The Journal of Immunology. 198(6). 2479–2488. 70 indexed citations
15.
Trejbalová, Kateřina, Jana Blažková, Ladislav Machala, et al.. (2016). Development of 5‘ LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals. Clinical Epigenetics. 8(1). 19–19. 51 indexed citations
16.
Chun, Tae‐Wook, Danielle Murray, J. Shawn Justement, et al.. (2014). Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir. Proceedings of the National Academy of Sciences. 111(36). 13151–13156. 61 indexed citations
17.
Blažková, Jana, Danielle Murray, J. Shawn Justement, et al.. (2012). Paucity of HIV DNA Methylation in Latently Infected, Resting CD4 + T Cells from Infected Individuals Receiving Antiretroviral Therapy. Journal of Virology. 86(9). 5390–5392. 77 indexed citations
18.
Kalina, Jiří, Filip Šenigl, Jitka Mucksová, et al.. (2007). Retrovirus-mediated in vitro gene transfer into chicken male germ line cells. Reproduction. 134(3). 445–453. 30 indexed citations
19.
Blažková, Jana, et al.. (2006). CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues. Experimental Cell Research. 312(7). 1011–1020. 83 indexed citations
20.
Gondois‐Rey, Françoise, Angélique Biancotto, Jana Blažková, et al.. (2005). R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L−CD4+T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. Journal of Virology. 80(2). 854–865. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hind J. Fadel Breakdown of academic impact, for papers by Vincent Baillat Breakdown of academic impact, for papers by Zhiyuan Yang Breakdown of academic impact, for papers by Gian Paolo Rizzardi Breakdown of academic impact, for papers by Fiona Wightman Breakdown of academic impact, for papers by John Delehanty Breakdown of academic impact, for papers by Hwee L. Ng Breakdown of academic impact, for papers by Yuyang Tang Breakdown of academic impact, for papers by Catherine Riou
Rankless by CCL
2026